ID   T24T SL3
AC   CVCL_RN65
SY   SL3
DR   cancercelllines; CVCL_RN65
DR   Wikidata; Q54971476
RX   PubMed=19147813;
RX   PubMed=29732388;
CC   Population: Caucasian; Swedish.
CC   Characteristics: Produced by passage of the parent cell line through nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RN64 ! T24T SL2
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
RX   PubMed=19147813; DOI=10.2353/ajpath.2009.080538; PMCID=PMC2630547;
RA   Smith S.C., Nicholson B., Nitz M.D., Frierson H.F. Jr., Smolkin M.,
RA   Hampton G.M., El-Rifai W., Theodorescu D.;
RT   "Profiling bladder cancer organ site-specific metastasis identifies
RT   LAMC2 as a novel biomarker of hematogenous dissemination.";
RL   Am. J. Pathol. 174:371-379(2009).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//